Clinical Trials Logo

Clinical Trial Summary

To prove, if preoperative elective anemic patients improve their hemoglobin levels within 3-6 weeks preoperativly after daily oral dietary supplementation of 60mg sucrosomal iron.


Clinical Trial Description

Patients with preoperative anemia have a poorer perioperative outcome in morbidity and mortality as part of surgery. Oral iron preparations have so far had poor bioavailability (approx. 30%) and mostly gastrointestinal side effects that often lead to discontinuation of treatment. Intravenous iron preparations also have an increased risk of allergic disease, which has already led to deaths in Austria. Oleovital® Eisen Forte shows improved bioavailability and hardly any gastrointestinal side effects. It should be improved in anemic patients by oleovital iron forte the hemoglobin content of the blood before surgery. Preoperative anemia is a relatively common problem that has not been preoperatively treated so far and therefore studies such as the one present here are very relevant.

The dietary supplement (Oleovital® Eisen Forte) has been on the market in Austria for iron substitution since autumn 2016. Oleovital® Eisen Forte seems suitable to produce a physiological hemoglobin content. The improved galenics is without previously known gastrointestinal side effects and should be investigated in an oral dose of 2 x 30mg (=60mg) p.o. per day over a limited intake of 3-6 weeks due to increased physiological iron demand.

The main objective of the study following a confirmant approach is to verify whether a sufficiently high number of anemic patients benefit from the oral intake of a high bioavailability iron preparation (Oleovital® Eisen Forte) in the last three to six weeks before an elective intervention (profit = response = increase in hemoglobin concentration by at least 1g/dl).

This controlled, randomized, open, prospective, monocentric study (two-armed parallel group design) should be classified as a food study (application of the commercial dietary supplement Oleovital® Eisen Forte) in an interventional setting - study-specific measures: additional blood tests and intake of Oleovital® Eisen Forte, in certain cases additional for a study-specific blood test are re-quired.

There are two study arms or groups:

- Group V = Verumgroup with iron supplementation by Oleovital® Eisen Forte

- Group K = Control group without iron supplementation - This group receives the usual treatment in the hospital.

Furthermore, stratification is carried out according to the sub-collectives

- "Patients without menstrual bleeding" (subcollective A) and

- "Patients with menstrual bleeding" (subcollective B) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04351607
Study type Interventional
Source Mein Hanusch-Krankenhaus
Contact Alexander Loeckinger, M.D.
Phone +43191021
Email alexander.loeckinger@oegk.at
Status Recruiting
Phase N/A
Start date October 1, 2019
Completion date October 1, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03516734 - Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh N/A
Completed NCT02570854 - A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients Phase 1
Completed NCT02887963 - Epidemiological Study of Iron Deficiency and Iron Deficiency Anemia in Chinese Pregnant Women N/A
Completed NCT00534144 - Comparison Between Effects of Two Iron Preparations on Protein in the Urine Phase 1
Completed NCT00224081 - DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin) Phase 4
Recruiting NCT02999217 - Intravenous Iron for Correction of Anaemia After Colorectal Surgery Phase 4
Completed NCT04163406 - The Effect of Human Milk Oligosaccharides and Galacto-oligosaccharides on Iron Absorption in Kenyan Infants N/A
Completed NCT02365103 - Tea Consumption and Iron Bioavailability in Women Using a Stable Isotope N/A
Completed NCT00536666 - A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients Phase 3
Completed NCT02310607 - Non-invasive Optical Detection of Iron Deficiency N/A
Completed NCT01755455 - Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis N/A
Terminated NCT00929409 - Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia Phase 2/Phase 3
Completed NCT00354692 - Effect of Two Iron Preparations on Protein in the Urine Phase 4
Recruiting NCT05628896 - Efficacy of a Preoperative Anaemia Clinic in Patients Undergoing Elective Abdominal Surgery
Completed NCT02905539 - A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer Phase 4
Completed NCT02892461 - Effect of Umbilical Cord Milking on Iron Related Health Outcomes for Cesarean-Delivered Infants N/A
Not yet recruiting NCT01840384 - Efficacy Study of Multiple Micro Nutrients Supplementation N/A
Recruiting NCT00125996 - Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure Phase 1/Phase 2
Not yet recruiting NCT04975074 - Iron Deficiency Anemia in Twin Pregnancies Phase 4
Completed NCT03565354 - Efficacy of Preoperative Intravenous Iron in Anaemic Colorectal Cancer Surgical Patients Phase 3